The chemical class designated as GS2 Inhibitors represents a diverse array of compounds characterized by their ability to modulate the activities of the GS2 protein. GS2 is a pivotal component in cellular processes, particularly in vesicle trafficking and related cellular mechanisms. These inhibitors, while not directly antagonizing GS2, function by influencing the cellular systems and pathways closely associated with its activities. This class demonstrates a broad spectrum of actions, ranging from altering gene expression and chromatin structure to impacting signal transduction and protein synthesis. Their mechanisms of action are rooted in their ability to interact with the molecular pathways that GS2 influences, thereby modulating its activity in a more indirect yet potent manner.
In this chemical class, each member functions by engaging with different facets of the cellular machinery that GS2 impacts. Some members of this class work by modulating gene expression mechanisms, a key domain of GS2 activity, thereby altering the transcriptional control landscape. Others focus on impacting chromatin architecture, thus influencing the accessibility and expression of genes regulated by GS2. There are also those that affect various signaling pathways, echoing the role of GS2 in cellular communication and response mechanisms. Additionally, certain inhibitors in this class target protein synthesis and cellular growth pathways, reflecting the importance of GS2 in these fundamental biological processes. Overall, the GS2 Inhibitors chemical class embodies a multifaceted approach to regulating a protein integral to numerous cellular pathways. This strategy showcases the nuanced and layered nature of targeting a protein like GS2, which is woven into the fabric of various cellular activities. The distinct mechanisms of action within this class underscore the complexity of modulating GS2 activity, reflecting the depth of understanding required to influence such a multifunctional protein effectively. As research progresses, these inhibitors will likely become increasingly refined, offering more insights into the sophisticated regulatory networks in which GS2 plays a pivotal role.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
NSC23766 is a Rac1 inhibitor known to disrupt cytoskeletal organization and vesicle trafficking, processes crucial for RAB27A's function. By targeting these pathways, NSC23766 may inhibit RAB27A's role in cellular transport mechanisms. | ||||||
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $265.00 | 14 | |
SecinH3 inhibits cytohesins, impacting ARF protein activation and vesicle transport. By disrupting these processes, it could inhibit GS2's role in the regulated movement of vesicles within the cell. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore, a dynamin inhibitor, is known to affect vesicle scission, a critical step in vesicle trafficking. Its action can potentially inhibit GS2's involvement in the transport and release of cellular vesicles. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A inhibits ARF GEFs, disrupting vesicle formation, a key process in vesicle trafficking where GS2 plays a significant role. This disruption can potentially inhibit GS2's function in vesicle-mediated transport. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, as a PI3 kinase inhibitor, affects intracellular signaling and vesicle trafficking. Its influence on these pathways can potentially inhibit GS2's role in cellular transport and signaling processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, another PI3 kinase inhibitor, impacts signaling pathways and vesicle trafficking. By affecting these processes, it can potentially inhibit GS2's function in vesicle transport and cell signaling. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 inhibits the Arp2/3 complex, affecting actin polymerization and vesicle movement. Its role in disrupting cytoskeletal dynamics can potentially inhibit GS2's function in vesicle trafficking. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, influencing cytoskeletal dynamics. This disruption can potentially inhibit GS2's involvement in vesicle transport and cellular structure maintenance. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin B affects cytoskeletal organization by disrupting actin polymerization. Its impact on cytoskeletal dynamics can potentially inhibit GS2's role in vesicle transport processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an MEK inhibitor that affects various signaling pathways. By influencing these pathways, it can potentially inhibit GS2's role in cell signaling and vesicle transport processes. | ||||||